GTM Playbook for Dermatology Practices in 2027
A dermatology practice should go to market as two businesses under one brand: a medical practice that wins on access, trust and referrals, and a cosmetic practice that wins on reputation, visible results and repeat treatment. The demand is real on both sides. The American Academy of Dermatology says acne affects up to 50 million Americans annually and psoriasis nearly 7.5 million, and the American Society of Plastic Surgeons counted over 28.5 million minimally invasive cosmetic procedures in 2024.
The working playbook has four moves: make the practice easy to find in local search with a verified, well-reviewed Google Business Profile; make it easy to book, because the published wait times for a new-patient visit are long; turn each medical visit into a trusted relationship that can later carry cosmetic care; and measure every step with a small set of KPIs. The sections below give the sourced facts behind each move and mark where no public benchmark exists, so you measure your own numbers instead of borrowing someone else's.
Compliance sits under all of it. Patient reviews and testimonials fall under the FTC rule on consumer reviews, and marketing messages to patients fall under the HIPAA marketing guidance from HHS.
Market facts: medical demand and cosmetic demand
Both halves of a dermatology practice have published demand data. These are national figures, not forecasts for your zip code:
- Acne (AAD)Affects up to 50 million Americans annually
- Eczema (AAD)Affects nearly 1 in 10 Americans of all ages
- Psoriasis (AAD)Affects nearly 7.5 million people in the United States
- Hair loss (AAD)An estimated 80 million Americans, 50 million men and 30 million women
- Minimally invasive cosmetic procedures (ASPS, 2024)Over 28.5 million; neuromodulator injections 9,883,711, hyaluronic acid fillers 5,331,426, skin resurfacing 3,703,305
- Cosmetic consideration (ASDS 2025 survey)70% of more than 3,500 consumers surveyed were considering a cosmetic dermatologic procedure
Access is the medical-side constraint. A Merritt Hawkins survey reported by The Hospitalist found an average new-patient wait of 32.3 days in 2017, up from 28.8 days in 2014, with Philadelphia at 78 days and Miami at 11 days. That survey is dated and covered 286 dermatologists in 15 large cities, so treat it as proof that waits vary widely by market, and call your own competitors to learn the wait in yours.
On the cosmetic side, the ASDS survey as reported by Practical Dermatology says dermatologists are the physician of choice in 12 procedure categories and receive 95% or higher overall patient satisfaction in 8 of 15 treatments. The same survey gives the reasons people delay: cost (24%), fear of side effects (16%) and pain (14%). Those three objections are what your cosmetic messaging has to answer.
Positioning: medical versus cosmetic services
Medical dermatology is chosen on access and clinical trust. Cosmetic dermatology is chosen on perceived skill and results. One brand can hold both, but the pages, offers and front-desk scripts should not blur them.
- Lead medical messaging with access. Same-week availability for rashes, acne and skin checks is the claim a long-wait market cannot match. Only publish an availability claim you can keep.
- Lead cosmetic messaging with physician credentials. The ASDS survey above reports dermatologists as the physician of choice in 12 procedure categories, which supports a board-certified, skin-first position against non-physician injectors.
- Use medical patients as the cosmetic pipeline. A patient who already trusts the practice for a skin condition is the warmest cosmetic lead you will have. Offer, never push, and respect the marketing rules in the compliance section.
- Answer the three delay reasons. Publish pricing logic for cost, plain safety information for side-effect fear, and what a treatment feels like for pain.
Patient acquisition channels and what is known about each
Public benchmarks for dermatology cost per lead or cost per acquisition are not published by a source I could verify, so this section sticks to what the sources do say and tells you what to measure.
- Google Business Profile and local search. Google's help page says local ranking rests on relevance, distance and prominence, that verifying the business makes it more likely to show up, and that more reviews and positive ratings can help local ranking. It also says replying to reviews shows you value feedback. Claim and verify every location, keep services and hours accurate, and reply to every review.
- Reviews and rating sites. In the ASDS survey, 94% said rate and review websites play a role in provider choice, and almost half said a provider's social media presence affects their decision to book a consultation. Reviews are an acquisition channel, not a courtesy.
- Social media for cosmetic services. Use it for education and consented before-and-after content. Track consultations booked from each platform rather than followers.
- Referrals from primary care physicians and other practices. No public conversion benchmark exists that I could verify. Track referral source on every new-patient record and measure which referrers send patients who actually show up.
- Paid search. Bid on high-intent searches such as the procedure plus your city, send traffic to a page for that one service with a booking button, and compare cost per booked new patient to your own average first-year revenue. No source gives a trustworthy dermatology benchmark, so your own call tracking is the benchmark.
The patient journey and front-desk booking conversion
The journey is search, profile, website, call or online request, booking, visit, follow-up. Most leaks happen at the call and the booking step, and that is where the long-wait finding matters: if the competitor down the road quotes weeks, a practice that offers a visit quickly or a waitlist call-back wins the patient.
- Answer every inbound call and form fast. Log each inquiry with its source, then log whether it booked. Booking rate is inquiries booked divided by inquiries received; no source I could verify publishes a dermatology benchmark, so set your own baseline first.
- Separate scripts for medical and cosmetic callers. A caller with a rash needs a clinical triage and the earliest slot. A caller asking about fillers needs a consultation offer and a clear price range.
- Offer online booking and a waitlist. Both reduce the cost of a missed call. Review waitlist fill rates weekly.
- Reduce no-shows by patient group. A scoping review of 22 articles summarized by Healio reports that 20.6% of Medicaid patients missed appointments without notice versus 9.8% of privately insured patients, and that two studies found video-based teledermatology was associated with significantly lower no-show rates. Only four of the 22 studies tested a strategy, so test reminders and teledermatology for yourself.
Pricing and memberships for cosmetic services
Cost is the most-cited reason for delaying a cosmetic treatment in the ASDS survey (24%), so price presentation is part of go-to-market, not an afterthought. I found no sourced benchmark for dermatology membership pricing or take-up, so no price or uptake figure is given here.
- Publish pricing logic. Show what is priced per unit, per syringe or per session, and what a consultation covers. Hidden pricing is where cost-driven delay gets worse.
- Consider a membership or treatment plan. Neuromodulators and fillers are repeat treatments, which is why they are the two largest categories in the ASPS count. A plan that bundles repeat visits gives you predictable revenue and gives the patient a reason to return. Model it against your actual repeat rate before you launch.
- Keep medical billing separate. Medical visits are billed under insurance rules and cosmetic services are typically self-pay; keep the offers, consent forms and payment flows distinct.
Retention and recall
Acquisition is the expensive part, so recall is where a dermatology practice earns margin. Skin checks, chronic conditions such as psoriasis and eczema, and repeat cosmetic treatments all have a natural return interval, and the AAD figures above show how large the chronic population is.
- Set a recall at checkout. Book or flag the next visit before the patient leaves, using the interval the clinician orders.
- Run recall lists monthly. List patients overdue for a skin check or a repeat treatment, and contact them through the channel they agreed to.
- Ask for a review at the right moment. Ask after a good visit, to every patient, and never offer payment for a positive review. See the compliance section.
- Check marketing consent before any promotional message. Appointment reminders and promotional offers are different things under HIPAA, as the compliance section explains.
KPIs to track
No public source I could verify publishes a dermatology-wide benchmark for these, so the formulas below are the point. Compute them monthly, by service line (medical and cosmetic) and by location.
- New patients per monthCount of first-time patients seen, split by medical and cosmetic and by source
- No-show rateMissed appointments divided by scheduled appointments, split by payer type and visit type
- Cost per acquisitionMarketing spend on a channel divided by new patients who completed a first visit from that channel
- Revenue per visitCollected revenue divided by completed visits, kept separate for medical and cosmetic
- Booking rateInquiries that became appointments divided by inquiries received
- Recall rateOverdue patients who rebooked divided by overdue patients contacted
The Healio review shows why a single no-show number can hide a problem: rates differed between Medicaid and privately insured patients, so split the metric before you act on it.
Compliance notes: HIPAA marketing and FTC review rules
This is a summary of public guidance, not legal advice. Have a healthcare attorney review your marketing.
- HIPAA marketing. HHS guidance says that if a communication is marketing, a covered entity generally may send it only with the individual's authorization. The final rule requires authorization for all paid communications that recommend a product or service, and keeps exceptions for face-to-face communications and promotional gifts of nominal value. Get written authorization before using a patient's information, photos or story in promotion.
- FTC reviews and testimonials. The FTC rule went into effect on October 21, 2024. It addresses deceptive conduct involving consumer reviews and testimonials, and a business could be liable if it wrote or created fake or false reviews. Insiders who post reviews should clearly and conspicuously disclose their relationship to your business.
- Never pay for sentiment. The FTC press release lists paying or rewarding people on the condition that they write positive or negative reviews, and suppressing negative reviews through groundless legal threats or intimidation, among the banned conduct. The rule authorizes courts to impose civil penalties for knowing violations.
Questions people ask
How should a dermatology practice market medical and cosmetic services?
As two service lines under one trusted brand. Lead medical messaging with access and clinical trust, and cosmetic messaging with physician credentials and results. The ASDS survey says dermatologists are the physician of choice in 12 procedure categories.
What is the best patient acquisition channel for a dermatology practice?
No source I could verify ranks channels for dermatology. Google's guidance says reviews and verification help local ranking, and the ASDS survey says 94% of respondents said rate and review websites play a role in provider choice, so start with a verified, well-reviewed Google Business Profile and measure cost per new patient by channel.
How big is cosmetic demand in dermatology?
The ASPS 2024 statistics counted over 28.5 million minimally invasive procedures, led by 9,883,711 neuromodulator injections. In the ASDS survey, 70% of consumers were considering a cosmetic dermatologic procedure.
What is a good no-show rate for a dermatology practice?
I found no authoritative national benchmark. The Healio review reports 20.6% for Medicaid patients and 9.8% for privately insured patients in the studies it summarized, so measure your own rate by payer and visit type.
Can a practice ask patients for reviews and post testimonials?
Yes, with care. The FTC rule bans fake or false reviews, requires insiders to disclose their relationship, and the FTC press release lists paying for positive or negative reviews as prohibited. Under HHS HIPAA guidance, using patient information in marketing generally requires authorization.
Sources
- American Academy of Dermatology: Skin conditions by the numbers · Acne, eczema, psoriasis and hair loss prevalence
- American Society of Plastic Surgeons: 2024 statistics · Minimally invasive procedure counts
- Practical Dermatology: 2025 ASDS consumer survey · Consideration, delay reasons, review-site influence
- Google Business Profile Help: improve your local ranking · Relevance, distance, prominence, reviews
- The Hospitalist: dermatologist wait times (Merritt Hawkins) · New-patient wait times, 2017 survey
- Healio: patients most likely to be no-shows · Dermatology no-show scoping review
- FTC: Consumer Reviews and Testimonials Rule Q&A · Fake reviews, insider disclosure, effective date
- FTC: final rule banning fake reviews and testimonials · List of banned conduct
- HHS: HIPAA marketing guidance · Authorization for marketing communications
Figures were read from the linked pages on October 18, 2026. The wait-time survey is from 2017 and the no-show figures come from published studies, not a national dermatology benchmark; use them to frame your own measurements.